Overview

Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.

Status:
Not yet recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The study purpose is to evaluate the safety of T4090.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Laboratoires Thea